AADI BIOSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | -5.66% |
|
+7.53% | -0.99% |
| 13/03 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
| 13/03 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
Chart calendar Aadi Bioscience, Inc.
f5845a51.hxrW7hFLYxpwIPVzoF0JyS4Uow3LE2Lol_Qtlbt0Fao.xVWejCcyG3URa50l2gJcmHpN9D67SgCPw8Ry5d9MYJPLd4anJzE5SiVong~751381b5cf65937e6c5f06d383de8034
Upcoming events on Aadi Bioscience, Inc.
Past events on Aadi Bioscience, Inc.
| 10/04/2024 06:30 pm | American Association for Cancer Research Meeting - Abstract Number: 7196 |
| 09/04/2024 11:00 pm | American Association for Cancer Research Meeting - Abstract Number: 6486 |
| 19/03/2024 12:15 am | Society of Gynecologic Oncology Meeting - Poster Number: 2126 |
| 19/03/2024 12:15 am | Society of Gynecologic Oncology Meeting - Poster Number: 2127 |
| 18/03/2024 02:15 am | Society of Gynecologic Oncology Meeting |
| 18/03/2024 01:45 am | Society of Gynecologic Oncology Meeting - Poster Number: 1176 |
| 13/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 13/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 05/03/2024 12:40 am | TD Cowen Health Care Conference |
| 28/01/2024 01:00 am | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 27/01/2024 08:30 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 27/01/2024 07:15 am | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 27/01/2024 01:00 am | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 20/01/2024 02:00 am | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS585 |
| 20/01/2024 02:00 am | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: 558 |
| 20/01/2024 02:00 am | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS601 |
| 15/12/2023 03:30 am | PRECISION1 Nab Sirolimus Trial Results Call |
| 14/11/2023 02:00 pm | Jefferies London Healthcare Conference |
| 08/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 08/11/2023 06:30 pm | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,12 0,06 1766.67% | 15,2 14,1 8.13% | 24,4 24,1 0.94% | 28,2 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -111 -112 1.13% | -62,7 -63,0 0.47% | -71,9 -72,9 1.36% | -76,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -110 -111 0.66% | -60,5 -62,7 3.44% | -65,8 -67,6 2.79% | -68,9 |
|
Net income Million USD | Released Forecast Spread | -111 -111 0.1% | -60,5 -62,7 3.48% | -65,8 -67,6 2.79% | -68,9 |
|
EPS USD | Released Forecast Spread | -12,4 -6,86 -80.9% | -2,69 -2,94 8.5% | -2,44 -2,49 2.09% | -2,49 |
| Announcement Date | 17/03/22 | 29/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,00 0,04 2677.78% | 2,31 0,42 454.03% | 3,44 3,26 5.52% | 4,25 3,86 9.95% | 5,23 4,65 12.4% | 5,87 5,96 -1.54% | 6,20 6,28 -1.16% | 5,96 6,50 -8.37% | 6,33 6,30 0.35% | 6,69 | 6,90 | 7,13 | 7,36 | 7,00 |
|
EBIT Million USD | Released Forecast Spread | -15,9 -14,2 -12.51% | -13,8 -15,4 10.45% | -18,4 -17,4 -5.82% | -15,0 -16,2 6.95% | -15,5 -15,8 1.92% | -16,8 -16,0 -5.16% | -19,5 -17,6 -11.29% | -17,8 -19,9 10.09% | -17,7 -18,5 4.29% | -18,4 | -18,6 | -18,7 | -19,9 | -21,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,0 -14,0 -14.08% | -13,9 -15,0 7.92% | -18,3 -17,3 -5.52% | -14,5 -16,1 10.2% | -13,9 -15,7 11.47% | -15,2 -15,9 4.19% | -18,0 -17,5 -2.58% | -16,3 -19,7 17.38% | -16,3 -18,0 9.48% | -16,9 | -17,1 | -17,1 | -17,9 | -21,3 |
|
Net income Million USD | Released Forecast Spread | -16,0 -14,0 -14.08% | -13,9 -15,0 7.92% | -18,3 -17,3 -5.57% | -14,5 -16,1 10.2% | -13,9 -15,7 11.52% | -15,2 -15,9 4.19% | -18,0 -17,5 -2.58% | -16,3 -19,7 17.38% | -16,3 -18,0 9.48% | -16,9 | -17,1 | -17,1 | -17,9 | -21,3 |
|
EPS USD | Released Forecast Spread | -0,77 -0,82 6.55% | -0,66 -0,71 7.3% | -0,87 -0,80 -8.75% | -0,68 -0,74 8.36% | -0,48 -0,71 32.39% | -0,57 -0,62 7.57% | -0,67 -0,61 -10.74% | -0,60 -0,73 17.81% | -0,60 -0,65 7.41% | -0,62 | -0,63 | -0,60 | -0,64 | -0,78 |
| Announcement Date | 17/03/22 | 12/05/22 | 10/08/22 | 09/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 13/03/24 | - | - | - | - | - |
| Today 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
| Today 05:00 pm | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 05:25 pm | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 13/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Aadi Bioscience, Inc.
| Today | BIOTEST AG: Q1 2024 Earnings Release |
| Today | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| Today | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 05:20 pm | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 04:30 pm | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AADI Stock
- Calendar Aadi Bioscience, Inc.